featured
Empagliflozin as Adjunct to Insulin Effective in Type 1 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Empagliflozin as Adjunct to Insulin in Patients With Type 1 Diabetes: A 4-Week, Randomized, Placebo-Controlled Trial (EASE-1)
Diabetes Obes Metab 2015 Jun 24;[EPub Ahead of Print], TR Pieber, S Famulla, J Eilbracht, J Cescutti, N Soleymanlou, OE Johansen, HJ Woerle, UC Broedl, S KaspersFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.